Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-26-059559
Filing Date
2026-05-20
Accepted
2026-05-20 16:30:22
Documents
1
Period of Report
2026-05-14

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4232
  Complete submission text file 0001213900-26-059559.txt   5651
Mailing Address 15150 AVENUE OF SCIENCE SUITE 200 SAN DIEGO CA 92128
Business Address
Townsend John (Reporting) CIK: 0001511906 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40582 | Film No.: 261004460

Mailing Address 1975 W. EL CAMINO REAL, SUITE 204 MOUNTAIN VIEW CA 94040
Business Address 1975 W. EL CAMINO REAL, SUITE 204 MOUNTAIN VIEW CA 94040 650-384-0642
Unicycive Therapeutics, Inc. (Issuer) CIK: 0001766140 (see all company filings)

EIN.: 813638692 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)